Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. 1996

S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
Second Department of Internal Medicine, Yamaguchi University School of Medicine, Japan.

BACKGROUND Aortic input impedance, which represents LV afterload, is considered to be a major determinant for the development of pressure-overload left ventricular (LV) hypertrophy. RESULTS To test whether the sustained change in aortic input impedance might affect the mode of development of LV hypertrophy, coarctation of either the ascending aorta (G1, n = 13) or suprarenal abdominal aorta (G2, n = 12) was performed over 4 weeks in 6-weeks-old Wistar rats. Although peak LV pressure and total systemic resistance were increased similarly in G1 and G2, time to peak LV pressure was decreased by 24% (P < .01) in G1 compared with G2. The aortic input impedance spectra revealed that the early systolic loading in G1 was characterized by an increase in characteristic impedance, whereas the late systolic loading in G2 was by an augmented arterial wave reflection. G1 showed a smaller increase (P < .01) in either the ratio of LV weight (mg) to body weight (g) or LV wall thickness than G2 after aortic banding. Myocyte diameter was also smaller (P < .05) in G1 (14.3 +/- 0.7 mm) than in G2 (16.1 +/- 1.2 mm). The ex vivo passive pressure-volume relation had a rightward shift in G1 compared with G2, suggesting less concentric LV hypertrophy in G1. CONCLUSIONS The sustained early systolic loading due to the increase in characteristic impedance was accompanied by less concentric, reduced hypertrophy, whereas the sustained late systolic loading due to the augmented arterial wave reflection was accompanied by concentric, adequate hypertrophy.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001012 Aorta, Abdominal The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries. Abdominal Aorta,Abdominal Aortas,Aortas, Abdominal

Related Publications

S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
October 2000, Journal of cardiovascular pharmacology,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
February 1996, Molecular and cellular biochemistry,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
October 1992, The American journal of physiology,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
April 1999, Circulation research,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
January 1982, Indian heart journal,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
January 1996, Journal of molecular and cellular cardiology,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
October 2000, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
June 2005, American journal of physiology. Heart and circulatory physiology,
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
May 2005, Hypertension (Dallas, Tex. : 1979),
S Kobayashi, and M Yano, and M Kohno, and M Obayashi, and Y Hisamatsu, and T Ryoke, and T Ohkusa, and K Yamakawa, and M Matsuzaki
March 1980, Cardiovascular research,
Copied contents to your clipboard!